Stock listing
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Selected listing: 002399 · SZSE · CNY · CN
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (Shenzhen:002399), Health Technology. Latest release May 11, 2026: Resverlogix Announces One-Year…
- Ticker
- Shenzhen:002399
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shenzhen
- Currency
- CNY
About Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A is a publicly traded company in China, listed under the ticker 002399. Hepalink specializes in the development and production of heparin and other pharmaceutical products.
Latest news from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Resverlogix Announces One-Year Extension of Debenture
May 11, 2026
Shenzhen Hepalink Pharmaceutical : RESIGNATION OF VICE CHAIRMAN AND EXECUTIVE DIRECTOR
May 6, 2021
Shenzhen Hepalink Pharmaceutical : VOLUNTARY ANNOUNCEMENT"HEPTRIS" OBTAINS APPROVAL FROM BRAZILIAN HEALTH REGULATORY AGENCY
April 21, 2021
Shenzhen Hepalink Pharmaceutical : (1) RESIGNATION OF NON-EXECUTIVE DIRECTOR (2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR
April 20, 2021
Shenzhen Hepalink Pharmaceutical : VOLUNTARY ANNOUNCEMENT - "INHIXA" OBTAINS APPROVAL FROM NORTH MACEDONIA
April 13, 2021
All Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A news →
Research Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A company profile
View the public company page for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A on 6ix.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A news
Read company news and market updates connected to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A.